Q3 2019 Holdings
Filed 2019-11-14 | 95 holdings | $285.9M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Brookdale SR Living Inc(BKD) | COM | 112463104 | $54.6M | 7,207,239 | 19.1% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $32.0M | 281,000 | 11.2% |
| Coherus Biosciences Inc(CHRS) | COM | 19249H103 | $31.2M | 1,540,305 | 10.9% |
| Centene Corp del(CNC) | COM | 15135B101 | $31.2M | 720,400 | 10.9% |
| Alector Inc(ALEC) | COM | 014442107 | $29.9M | 2,076,812 | 10.5% |
| Axogen Inc(AXGN) | COM | 05463X106 | $23.0M | 1,842,330 | 8.0% |
| Addus Homecare Corp(ADUS) | COM | 006739106 | $20.1M | 252,915 | 7.0% |
| Arvinas Inc(ARVN) | COM | 04335A105 | $19.9M | 921,234 | 6.9% |
| Ardelyx Inc(ARDX) | COM | 039697107 | $16.0M | 3,400,410 | 5.6% |
| Biocryst Pharmaceuticals(BCRX) | COM | 09058V103 | $7.9M | 2,774,643 | 2.8% |
| Atricure Inc(ATRC) | COM | 04963C209 | $7.3M | 292,777 | 2.6% |
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $6.2M | 290,000 | 2.2% |
| Alphatec Holdings Inc(ATEC) | COM NEW | 02081G201 | $2.7M | 536,517 | 0.9% |
| Castle Biosciences Inc(CSTL) | COM | 14843C105 | $1.7M | 92,477 | 0.6% |
| Horizon Therapeutics PUB LTD | SHS | G46188101 | $176.0K | 6,462,634 | 0.1% |
| Horizon Pharma Invt LTD | NOTE 2.500% 3/1 | 44052TAB7 | $158.1K | $136,032,000 | 0.1% |
| Mylan N V | SHS EURO | N59465109 | $151.4K | 7,654,065 | 0.1% |
| Nevro Corp | NOTE 1.750% 6/0 | 64157FAA1 | $131.4K | $115,776,000 | 0.0% |
| Orchard Therapeutics PLC | ADS | 68570P101 | $106.0K | 8,923,600 | 0.0% |
| Homology Medicines Inc | COM | 438083107 | $104.3K | 5,760,368 | 0.0% |
| Aerie Pharmaceuticals Inc(AERIEUR) | COM | 00771V108 | $87.8K | 4,568,824 | 0.0% |
| Rhythm Pharmaceuticals Inc(RYTM) | COM | 76243J105 | $55.9K | 2,589,291 | 0.0% |
| Intersect ENT Inc | COM | 46071F103 | $52.9K | 3,109,004 | 0.0% |
| Acceleron Pharma Inc(XLRN) | COM | 00434H108 | $51.6K | 1,305,174 | 0.0% |
| Myokardia Inc | COM | 62857M105 | $51.2K | 981,430 | 0.0% |
| Intercept Pharmaceuticals in | NOTE 3.250% 7/0 | 45845PAA6 | $49.5K | $57,791,000 | 0.0% |
| Immunomedics Inc(IMMU) | COM | 452907108 | $42.6K | 3,214,000 | 0.0% |
| Clovis Oncology Inc | NOTE 2.500% 9/1 | 189464AB6 | $42.3K | $49,064,000 | 0.0% |
| RA Pharmaceuticals Inc | COM | 74933V108 | $40.9K | 1,728,019 | 0.0% |
| Mirum Pharmaceuticals Inc(MIRM) | COM | 604749101 | $34.7K | 3,448,912 | 0.0% |
| Kempharm Inc | NOTE 5.500% 2/0 | 488445AB3 | $32.2K | $62,423,000 | 0.0% |
| Silk Road Medical Inc | COM | 82710M100 | $31.9K | 979,480 | 0.0% |
| Vericel Corp(VCEL) | COM | 92346J108 | $31.5K | 2,081,000 | 0.0% |
| Fate Therapeutics Inc(FATE) | COM | 31189P102 | $30.3K | 1,952,897 | 0.0% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $28.8K | 382,000 | 0.0% |
| Select MED Hldgs Corp(SEM) | COM | 81619Q105 | $28.4K | 1,714,099 | 0.0% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $27.7K | 377,200 | 0.0% |
| DBV Technologies S A | SPONSORED ADR | 23306J101 | $27.5K | 3,201,222 | 0.0% |
| Sientra Inc | COM | 82621J105 | $26.8K | 4,137,470 | 0.0% |
| Tandem Diabetes Care Inc(TNDM) | COM NEW | 875372203 | $26.8K | 454,334 | 0.0% |
| Editas Medicine Inc(EDIT) | COM | 28106W103 | $26.4K | 1,158,841 | 0.0% |
| PTC Therapeutics Inc | NOTE 3.000% 8/1 | 69366JAB7 | $25.9K | $24,877,000 | 0.0% |
| DFB Healthcare Acquistion Co | UNIT 01/30/2023 | 23291E208 | $25.8K | 2,500,000 | 0.0% |
| Springworks Therapeutics Inc | COM | 85205L107 | $22.8K | 1,050,888 | 0.0% |
| Xeris Pharmaceuticals Inc | COM | 98422L107 | $22.7K | 2,308,666 | 0.0% |
| Molina Healthcare Inc(MOH) | COM | 60855R100 | $21.6K | 197,056 | 0.0% |
| Rocket Pharmaceuticals Inc(RCKT) | COM | 77313F106 | $20.7K | 1,773,938 | 0.0% |
| Deciphera Pharmaceuticals in(DCPHEUR) | COM | 24344T101 | $20.2K | 594,725 | 0.0% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $18.2K | 233,000 | 0.0% |
| Humana Inc(HUM) | COM | 444859102 | $17.1K | 67,000 | 0.0% |